Radioiodine therapy of thyroid autonomy

Area of Science:

• Endocrinology
• Nuclear Medicine
• Radiology

Background:

• Thyroid functional autonomy (TFA) causes subclinical hyperthyroidism with cardiovascular risks.
• Current diagnostic methods like TSH assays and ultrasounds lack accuracy for TFA variants.
• Radioiodine therapy (RIT) is an evolving, effective treatment for toxic nodular thyroid disease.

Purpose of the Study:

• To review modern diagnostic tools for TFA and its variants (unifocal, multifocal, disseminated autonomy).
• To explore the role of dosimetry and TSH modulation in optimizing RIT for TFA.
• To summarize clinical and dosimetric results of RIT in TFA management.

Main Methods:

• Utilizing Thyroid Scan imaging and quantification for TFA diagnosis.
• Applying a new predictive relationship for 123I uptake in compensated TFA.
• Reviewing dosimetry, target mass determination, and TSH level adjustment (LT3/ATD).

Main Results:

• Diagnostic accuracy of sensitive TSH assays and ultrasounds is limited for TFA.
• Thyroid Scan imaging and quantification are crucial for TFA diagnosis and variant identification.
• Dosimetry, considering spatial dose distribution and TSH modulation, refines RIT efficacy.
• RIT with TSH stimulation (ATD) shows promise for large autonomous goiters.
• Preventive RIT with short-term LT3 suppression in compensated TFA yielded successful results with low activity and hypothyroidism rates.

Conclusions:

• Accurate diagnosis of TFA and its variants requires advanced imaging and functional assessment.
• Optimized dosimetry and TSH modulation are key to successful RIT in TFA.
• RIT offers effective treatment for TFA with potential for preventive strategies to minimize hypothyroidism.